Becton Dickinson (BDX) Buy, Sell or Hold

Becton Dickinson (BDX)

143.96

-0.02 (0.01%)

as of Jun 18, 2026, 7:59:59 pm Market Open.

109 watching

TOP PICK

Medical technology. 38 years of consecutive dividend increases. Conservative payout ratio of 28%. 3 segments, medical, diagnostics and biosciences. All 3 have been growing at about 4%-5%. Met or exceeded earnings expectations for the last 5 years, usually 5%.

PAST TOP PICK

(A Top Pick Dec 31/09. Up 7.42%.)

BUY

Diagnostics is probably a good area to consider.

TOP PICK

Medical devices. Selling into emerging markets where per capita spent on health care is very small. Generates a lot of free cash flow. Raised dividends over the last 37 years. Grown revenues from 2000 at 8% per year. Debt to cash flow is under 1X. Very stable business.

TOP PICK

Hospital supply company in the US and will benefit when 40-50 million more people are covered under a healthcare plan. Trading at 13.5X earnings. Great growth record.

TOP PICK

So shareholder friendly in all the actions they have taken. Dividends rising for 36 years in a row. No debt, buying back shares. Modest growth, likes sector and dividend, which grows.

BUY

Manufactures medical devices. Looking for it to earn about $5.50 next year. Very steady, highly predictable.

BUY

Just recently purchased this. Has good revision and good valuation in the healthcare space. Products include syringes, monitors, catheters, etc. which healthcare services are in constant need of. Good growth and demand even when everything else is weak. Have some concerns on foreign exchange and margin issues because of increase in costs of raw materials. Expecting about 10% earnings growth in 2009, which is a great earnings profile.

BUY

If you go to a hospital in the US and look around, everywhere you go you see their products. There is a lot of concern that hospitals are not going to be able to spend the money that they have in the past so the stock has come down a long ways.

TOP PICK

Hospital supplies such as syringes, tests of blood supplies, etc. Off the radar on healthcare reform and pricing reform. Well diversified geographically with about 65% outside the US. Trading at 14 X earnings and looking at 12% growth.

TOP PICK

Hospital supplies. 16-18% growth in earnings over the last 10 years and expected to do the same in the next 5. Not expected to be impacted by the health care costs in the US. Strong balance sheet.

BUY

Hospital supply company as well as doing a lot of diagnostics testing. Had disappointing performance in the near term, but she likes it longer term. Growing at 18% to 17% with 60% to 70% of its profits outside of North America.

BUY

Great international company.

BUY

Medical supplies. Long time favourite. Unlike big pharma, has been delivering in terms of earnings 1st quarter was up almost 18%, well above expectations. Should continue to generate great returns, probably in the 10% to 12% range. Great international exposure.

HOLD

A leader in medical supplies with the main product being needles. Great stock and great company but right now, the valuation is not there.

Showing 61 to 75 of 83 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Becton Dickinson (BDX)